Viemed Healthcare (VMD) Total Current Liabilities (2018 - 2026)
Viemed Healthcare's (VMD) quarterly Total Current Liabilities came in at $40.7 million in Q1 2026, up 14.71% YoY from $35.5 million in Q1 2025, and down 0.85% on a QoQ basis from $41.1 million in Q4 2025.
Viemed Healthcare (VMD) Total Current Liabilities (2018 - 2026) Analysis & Trends
Viemed Healthcare (VMD) has 9 years of Total Current Liabilities data on file, last reported at $40.7 million in Q1 2026.
- Quarterly Total Current Liabilities rose 14.71% year-over-year to $40.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.7 million (up 14.71% YoY) and the FY2025 annual result came in at $41.1 million, up 9.99% from the prior year.
- Total Current Liabilities retreated to $40.7 million in Q1 2026, from $41.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $44.2 million in Q3 2025 to a low of $17.7 million in Q1 2022.
- A 5-year average of $31.0 million and a median of $31.6 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities declined 18.86% — and 2023, when it surged 76.8%.
- Tracing VMD's Total Current Liabilities over 5 years: stood at $18.9 million in 2022, then jumped by 70.32% to $32.1 million in 2023, then advanced by 16.19% to $37.3 million in 2024, then increased by 9.99% to $41.1 million in 2025, then slipped by 0.85% to $40.7 million in 2026.
- The last three Total Current Liabilities figures came in at $40.7 million (Q1 2026), $41.1 million (Q4 2025), and $44.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Viemed Healthcare | 332.74 Mn | 322.06 Mn | 45.05 Mn | 47.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.89 Mn |
| Mar 31, 2026 | 40.71 Mn |
| Dec 31, 2025 | 41.06 Mn |
| Sep 30, 2025 | 44.19 Mn |
| Jun 30, 2025 | 37.27 Mn |
| Mar 31, 2025 | 35.49 Mn |
| Dec 31, 2024 | 37.33 Mn |
| Sep 30, 2024 | 36.44 Mn |
| Jun 30, 2024 | 31.48 Mn |
| Mar 31, 2024 | 30.12 Mn |
| Dec 31, 2023 | 32.12 Mn |
| Sep 30, 2023 | 31.55 Mn |
| Jun 30, 2023 | 31.58 Mn |
| Mar 31, 2023 | 23.42 Mn |
| Dec 31, 2022 | 18.86 Mn |
| Sep 30, 2022 | 20.56 Mn |
| Jun 30, 2022 | 17.86 Mn |
| Mar 31, 2022 | 17.73 Mn |
| Dec 31, 2021 | 17.81 Mn |
| Sep 30, 2021 | 20.20 Mn |